echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > BeiGene Releases 2021 Environmental, Social and Governance (ESG) Report

    BeiGene Releases 2021 Environmental, Social and Governance (ESG) Report

    • Last Update: 2022-05-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    <>


    "At BeiGene, we're committed to being a transformative company that brings access to more patients around the world," said John V.


    In the past year, BeiGene officially established the ESG functional department and launched a new ESG strategic framework with the theme of " Change the future ?" , focusing on five key focus areas to meet the needs of different stakeholders


    1. Advancing Global Health: Innovative Medicines; Access and Affordability
    2. Empowering Employees: Diversity, Equity and Inclusion (DEI); Employee Engagement and Wellbeing
    3. Sustainable Innovation: Climate Change; Product Stewardship
    4. Supporting Communities: Patient Engagement and Advocacy; Charitable Giving and Volunteering
    5. Responsible Operations: Business Ethics and Integrity; Responsible Sourcing

    Christine Riley Miller, head of ESG at BeiGene, said: "While our ESG is still in the early stages of development, I am proud of the progress the company has made over the past year


    BeiGene’s 2021 ESG Report is based on the Global Reporting Initiative (GRI) standards.


    • The company has nearly 50 commercial products and clinical candidates in clinical development; more than 30 pivotal or potential registration trials are underway in more than 45 countries and regions; more than 50 preclinical research projects, of which nearly 50% Possess "first-in-class" or "best-in-class" potential;
    • In China, we have 16 approved commercial products.


      BeiGene is a science-based global biotechnology company focused on developing innovative, affordable medicines designed to improve outcomes and improve access to medicines for patients around the world


      Forward-Looking Statements 

      This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding BeiGene ESG's plans, commitments, retaliations and objectives.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.